title: Hypopigmented mycosis fungoides in Egyptian patients.
abstract: Hypopigmented mycosis fungoides (HMF) is uncommon clinical variant that was commonly observed in dark-skinned individuals. We described the clinical characteristics, pathological features, immunohistochemical profile and prognosis of HMF in Egyptian patients. During the period from January 2004 to December 2011, we were able to diagnose and follow up 27 patients with HMF. The study included 18 males (66.7%) and 9 females (33.3%) with a mean age of 35.39 ±13.13 years. The duration ranged from 1 to 6 years with a mean of 3.26 ±1.7 years. The majority of patients were skin type IV (63%) and presented with multiple (88.9%), asymptomatic (74.1%), ill-defined (70.4%) and non-scaly (77.8%) lesions distributed on the trunk (81.5%). Histologically, epidermotropic lymphocytes were observed in 100%, basal alignment of lymphocytes in 81.5%, Pautrier's microabscesses in 29% and folliculotropism in 18.5%. Immunostaining showed predominance of epidermal CD8+ cells in 51.9% while in 29.6% CD4+ cells were predominant. Phototherapy was effective in 86.7% of patients with success rate 66.7% of narrow band (NB) ultraviolet-B and 80% of psoralen ultraviolet-A. HMF among Egyptians could be classified as non-aggressive epidermotropic cytotoxic CD8+ variant. It is common among middle age males with skin type IV and mostly well respond to phototherapy.
authors: Department of Dermatology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt. helnaby@yahoo.com
authors: Hussein M M
authors: HM
authors: Hassab-El-Naby
authors: Mohamed A
authors: MA
authors: El-Khalawany
mesh_terms: D000328:Adult; D015897:Comorbidity; D004534:Egypt / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D009182:Mycosis Fungoides / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D010789:Phototherapy; D010859:Pigmentation Disorders / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D012878:Skin Neoplasms / Q000453:epidemiology / Q000473:pathology* / Q000628:therapy; D012880:Skin Pigmentation; D016896:Treatment Outcome